Clinical Trial: Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Reunion

U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928753) titled 'Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Reunion' on April 08.

Brief Summary: Against the backdrop of a growing chikungunya epidemic in La Reunion, this prospective study will assess the real-life efficacy, safety and immunogenicity of IXCHIQ(R) vaccine in vulnerable individuals (seniors, comorbid patients), defined by the French Health Autority (HAS) as at risk of severe or complicated forms and/or chronic disabling forms (chronic arthritis, chronic fatigue phenotypes). This study will also provide input for the pre...